Yuan Neal, Botting Patrick G, Elad Yaron, Miller Shaun J, Cheng Susan, Ebinger Joseph E, Kittleson Michelle M
Smidt Heart Institute (N.Y., P.G.B., Y.E., S.C., J.E.E., M.M.K.), Cedars-Sinai Medical Center, Los Angeles, CA.
Division of Informatics, Department of Biomedical Sciences (Y.E., S.J.M.), Cedars-Sinai Medical Center, Los Angeles, CA.
Circ Heart Fail. 2021 Oct;14(10):e008573. doi: 10.1161/CIRCHEARTFAILURE.121.008573. Epub 2021 Sep 30.
An unprecedented shift to remote heart failure outpatient care occurred during the coronavirus disease 2019 (COVID-19) pandemic. Given challenges inherent to remote care, we studied whether remote visits (video or telephone) were associated with different patient usage, clinician practice patterns, and outcomes.
We included all ambulatory cardiology visits for heart failure at a multisite health system from April 1, 2019, to December 31, 2019 (pre-COVID) or April 1, 2020, to December 31, 2020 (COVID era), resulting in 10 591 pre-COVID in-person, 7775 COVID-era in-person, 1009 COVID-era video, and 2322 COVID-era telephone visits. We used multivariable logistic and Cox proportional hazards regressions with propensity weighting and patient clustering to study ordering practices and outcomes.
Compared with in-person visits, video visits were used more often by younger (mean 64.7 years [SD 14.5] versus 74.2 [14.1]), male (68.3% versus 61.4%), and privately insured (45.9% versus 28.9%) individuals (<0.05 for all). Remote visits were more frequently used by non-White patients (35.8% video, 37.0% telephone versus 33.2% in-person). During remote visits, clinicians were less likely to order diagnostic testing (odds ratio, 0.20 [0.18-0.22] video versus in-person, 0.18 [0.17-0.19] telephone versus in-person) or prescribe β-blockers (0.82 [0.68-0.99], 0.35 [0.26-0.47]), mineralocorticoid receptor antagonists (0.69 [0.50-0.96], 0.48 [0.35-0.66]), or loop diuretics (0.67 [0.53-0.85], 0.45 [0.37-0.55]). During telephone visits, clinicians were less likely to prescribe ACE (angiotensin-converting enzyme) inhibitor/ARB (angiotensin receptor blockers)/ARNIs (angiotensin receptor-neprilysin inhibitors; 0.54 [0.40-0.72]). Telephone visits but not video visits were associated with higher rates of 90-day mortality (1.82 [1.14-2.90]) and nonsignificant trends towards higher rates of 90-day heart failure emergency department visits (1.34 [0.97-1.86]) and hospitalizations (1.36 [0.98-1.89]).
Remote visits for heart failure care were associated with reduced diagnostic testing and guideline-directed medical therapy prescription. Telephone but not video visits were associated with increased 90-day mortality.
在2019年冠状病毒病(COVID-19)大流行期间,心力衰竭门诊护理出现了前所未有的向远程医疗的转变。鉴于远程医疗固有的挑战,我们研究了远程问诊(视频或电话)是否与不同的患者使用情况、临床医生的诊疗模式及治疗结果相关。
我们纳入了一个多机构医疗系统在2019年4月1日至2019年12月31日(COVID-19之前)或2020年4月1日至2020年12月31日(COVID-19时期)期间所有心力衰竭的门诊心脏病诊疗,结果包括10591次COVID-19之前的面对面诊疗、7775次COVID-19时期的面对面诊疗、1009次COVID-19时期的视频诊疗和2322次COVID-19时期的电话诊疗。我们使用多变量逻辑回归和Cox比例风险回归,并结合倾向评分加权和患者聚类分析来研究诊疗医嘱行为和治疗结果。
与面对面诊疗相比,视频诊疗在年龄较轻(平均64.7岁[标准差14.5]对74.2岁[14.1])、男性(68.3%对61.4%)和有私人保险(45.9%对28.9%)的人群中使用更为频繁(所有P<0.05)。非白人患者更频繁地使用远程诊疗(视频诊疗占35.8%,电话诊疗占37.0%,面对面诊疗占33.2%)。在远程诊疗期间,临床医生开出诊断性检查的可能性较小(视频诊疗与面对面诊疗相比的比值比为0.20[0.18 - 0.22],电话诊疗与面对面诊疗相比为0.18[0.17 - 0.19]),或者开具β受体阻滞剂(0.82[0.68 - 0.99],0.35[0.26 - 0.47])、盐皮质激素受体拮抗剂(0.69[0.50 - 0.96],0.48[0.35 - 0.66])或袢利尿剂(0.67[0.53 - 0.85],0.45[0.37 - 0.55])的可能性也较小。在电话诊疗期间,临床医生开具ACE(血管紧张素转换酶)抑制剂/ARB(血管紧张素受体阻滞剂)/ARNI(血管紧张素受体脑啡肽酶抑制剂;0.54[0.40 - 0.72])的可能性较小。电话诊疗而非视频诊疗与90天死亡率较高(1.82[1.14 - 2.90])以及90天内心力衰竭急诊就诊率较高(1.34[0.97 - 1.86])和住院率较高(1.36[0.98 - 1.89])的非显著趋势相关。
心力衰竭的远程诊疗与诊断性检查减少和指南指导的药物治疗处方减少相关。电话诊疗而非视频诊疗与90天死亡率增加相关。